Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Roche Holding — Foundation Medicine
Entity

Roche Holding — Foundation Medicine

Tracked across 3 events · 19 articles · First seen Jun 10, 2026 · Last active Jul 22, 2026

Sentiment
22
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (3)
4 50
Regulatory
Roche FDA Approves PTEN Assay
Impact: Roche Holding — Foundation Medicine, an affiliate of Roche, is a laboratory utilizing the VENTANA PTEN (SP218) RxDx Assay to help identify patients with PTEN protein loss.
Jun 12, 2026 · 6 articles
2 15
Tech
ctDNA test for Ra therapy selection
Impact: Mentioned as provider of FoundationOne Liquid CDx, a ctDNA test that may be used in similar contexts; potential beneficiary if ctDNA testing becomes standard.
Jul 17, 2026 · 6 articles
4 0
Business
SOPHiA_GENETICS appoints new CEO, Chairman
Impact: Troy Cox previously served as CEO of Roche Holding — Foundation Medicine, leading it through an acquisition by Roche.
Jun 10, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Roche Holding — Foundation Medicine live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.